Trastuzumab: Clinical Trials

3 trials for Trastuzumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 unknown. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 2, Unknown 1

Follow Trastuzumab: new trials by email Literature Review of Trastuzumab trials Research Report on Trastuzumab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
Cardiovascular Health Education and Gaming through Virtual Reality - Breast Cancer, Anthracycline Related Cardiotoxicity in Breast Cancer
Not applicableRecruitingVirginia Commonwealth University302026-05-202026-09-22
Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
Chest wall / breast radiation with or without lymph node region radiation.(For all of the enrolled patients) - Breast Cancer, Familial Male, Radiotherapy; Complications
Not applicableRecruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences1482024-01-122024-08-21
Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer
Candesartan - Cardiotoxicity, Breast Cancer
Not applicableUnknownSamsung Medical Center1362019-07-192020-06-12

Narrower conditions

Breast Neoplasms (3)  ·  Breast Cancer, Familial Male (1)  ·  Cardiotoxicity (1)

Broader conditions

Breast Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Cardiovascular Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Heart Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Radiation Injuries (1)  ·  Wounds and Injuries (1)

Interventions

candesartan (1)

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Samsung Medical Center (1)  ·  Virginia Commonwealth University (1)

Countries

China (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Arnethea Sutton, Ph.D (1)  ·  Bo Lan, MD (1)  ·  Fei Ma, MD (1)  ·  Shulian Wang, MD (1)  ·  Yirui Zhai, MD (1)

Results publications

PMID 28581356, PMID 28968163, PMID 34081848, PMID 35020465